Cargando…

Th1 cytokine interferon gamma improves response in HER2 breast cancer by modulating the ubiquitin proteasomal pathway

HER2 breast cancer (BC) remains a significant problem in patients with locally advanced or metastatic BC. We investigated the relationship between T helper 1 (Th1) immune response and the proteasomal degradation pathway (PDP), in HER2-sensitive and -resistant cells. HER2 overexpression is partially...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jia, Yongsheng, Kodumudi, Krithika N., Ramamoorthi, Ganesan, Basu, Amrita, Snyder, Colin, Wiener, Doris, Pilon-Thomas, Shari, Grover, Payal, Zhang, Hongtao, Greene, Mark I., Mo, Qianxing, Tong, Zhongsheng, Chen, Yong-Zi, Costa, Ricardo L.B., Han, Hyo, Lee, Catherine, Soliman, Hatem, Conejo-Garcia, Jose R., Koski, Gary, Czerniecki, Brian J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8058490/ https://www.ncbi.nlm.nih.gov/pubmed/33412308 http://dx.doi.org/10.1016/j.ymthe.2020.12.037

Ejemplares similares

Intratumoral delivery of dendritic cells plus anti-HER2 therapy triggers both robust systemic antitumor immunity and complete regression in HER2 mammary carcinoma
por: Ramamoorthi, Ganesan, et al.
Publicado: (2022)

Differentiation and Regulation of T(H) Cells: A Balancing Act for Cancer Immunotherapy
por: Basu, Amrita, et al.
Publicado: (2021)

Sequential Anti-PD1 Therapy Following Dendritic Cell Vaccination Improves Survival in a HER2 Mammary Carcinoma Model and Identifies a Critical Role for CD4 T Cells in Mediating the Response
por: Kodumudi, Krithika N., et al.
Publicado: (2019)

Intercepting Premalignant, Preinvasive Breast Lesions Through Vaccination
por: Zachariah, Nadia Nocera, et al.
Publicado: (2021)

Oncodriver inhibition and CD4(+) Th1 cytokines cooperate through Stat1 activation to induce tumor senescence and apoptosis in HER2+ and triple negative breast cancer: implications for combining immune and targeted therapies
por: Rosemblit, Cinthia, et al.
Publicado: (2018)

Murine Dendritic Cells Grown in Serum-Free Culture Show Potent Therapeutic Activity when Loaded with Novel Th Epitopes in an Orthotopic Model of HER2(pos) Breast Cancer
por: Showalter, Loral E., et al.
Publicado: (2021)

BSCI-01 INTRATHECAL DELIVERY OF DENDRITIC CELL VACCINE ERADICATES TUMOR GROWTH AND PROTECTS AGAINST LEPTOMENINGEAL DISEASE (LMD) RE-INOCULATION IN IMMUNOCOMPETENT HER2+ AND TRIPLE NEGATIVE BREAST CANCER (TNBC) LMD XENOGRAFT MODELS
por: Law, Vincent, et al.
Publicado: (2022)

A Murine Ommaya Xenograft Model to Study Direct-Targeted Therapy of Leptomeningeal Disease
por: Law, Vincent, et al.
Publicado: (2021)

Efficacy of intralesional injection with PV-10 in combination with co-inhibitory blockade in a murine model of melanoma
por: Pilon-Thomas, Shari, et al.
Publicado: (2014)

Intralesional Injection of Rose Bengal Induces a Systemic Tumor-Specific Immune Response in Murine Models of Melanoma and Breast Cancer
por: Toomey, Paul, et al.
Publicado: (2013)

Immune Checkpoint Blockade to Improve Tumor Infiltrating Lymphocytes for Adoptive Cell Therapy
por: Kodumudi, Krithika N., et al.
Publicado: (2016)

T cell mediated immunity after combination therapy with intralesional PV-10 and blockade of the PD-1/PD-L1 pathway in a murine melanoma model
por: Liu, Hao, et al.
Publicado: (2018)

Identification of Immunogenic MHC Class II Human HER3 Peptides that Mediate Anti-HER3 CD4(+) Th1 Responses and Potential Use as a Cancer Vaccine
por: Basu, Amrita, et al.
Publicado: (2022)

Current State of Cell Therapies for Breast Cancer
por: Gautam, Namrata, et al.
Publicado: (2022)

Intralesional Rose Bengal in melanoma elicits tumor immunity via HMGB1
por: Liu, Hao, et al.
Publicado: (2015)

Long-Term CD4(+) T-Cell and Immunoglobulin G Immune Responses in Oncology Workers following COVID-19 Vaccination: An Interim Analysis of a Prospective Cohort Study
por: Gallen, Corey, et al.
Publicado: (2022)

Intralesional rose bengal in melanoma elicits tumor immunity via activation of dendritic cells by the release of high mobility group box 1
por: Liu, Hao, et al.
Publicado: (2016)

Th1 cytokines in conjunction with pharmacological Akt inhibition potentiate apoptosis of breast cancer cells in vitro and suppress tumor growth in vivo
por: Showalter, Loral, et al.
Publicado: (2020)

T-helper 1-type cytokines induce apoptosis and loss of HER-family oncodriver expression in murine and human breast cancer cells
por: Namjoshi, Prachi, et al.
Publicado: (2019)

Thrombosis after SARS-CoV2 infection or COVID-19 vaccination: will a nonpathologic anti-PF4 antibody be a solution?—A narrative review
por: Rao, Elizabeth, et al.
Publicado: (2022)

A brief report of toxicity end points of HER2 vaccines for the treatment of patients with HER2(+) breast cancer
por: Costa, Ricardo, et al.
Publicado: (2019)

Proteasome- and Ethanol-Dependent Regulation of HCV-Infection Pathogenesis
por: Osna, Natalia A., et al.
Publicado: (2014)

Sunitinib Combined with Th1 Cytokines Potentiates Apoptosis in Human Breast Cancer Cells and Suppresses Tumor Growth in a Murine Model of HER-2(pos) Breast Cancer
por: Ghimirey, Nirmala, et al.
Publicado: (2021)

Immune interconnectivity of anatomically distant tumors as a potential mediator of systemic responses to local therapy
por: Walker, Rachel, et al.
Publicado: (2018)

Regulatory T Cells: Regulation of Identity and Function
por: Grover, Payal, et al.
Publicado: (2021)

Challenges in Detection of Serum Oncoprotein: Relevance to Breast Cancer Diagnostics
por: Lengfeld, Justin, et al.
Publicado: (2021)

Probiotic potential of lactic acid bacteria present in home made curd in southern India
por: Balamurugan, Ramadass, et al.
Publicado: (2014)

Majoon Chobchini attenuates arthritis disease severity and RANKL-mediated osteoclastogenesis in rheumatoid arthritis
por: Samarpita, Snigdha, et al.
Publicado: (2021)

Expansion of tumor infiltrating lymphocytes (TIL) from bladder cancer
por: Poch, Michael, et al.
Publicado: (2018)

T-cells produce acidic niches in lymph nodes to suppress their own effector functions
por: Wu, Hao, et al.
Publicado: (2020)

Neoadjuvant radiotherapy of early-stage breast cancer and long-term disease-free survival
por: Poleszczuk, Jan, et al.
Publicado: (2017)

Th1 cytokines sensitize HER-expressing breast cancer cells to lapatinib
por: Showalter, Loral E., et al.
Publicado: (2019)

Statin Drugs Plus Th1 Cytokines Potentiate Apoptosis and Ras Delocalization in Human Breast Cancer Lines and Combine with Dendritic Cell-Based Immunotherapy to Suppress Tumor Growth in a Mouse Model of HER-2(pos) Disease
por: Oechsle, Crystal M., et al.
Publicado: (2020)

A systematic review and meta-analysis of selected toxicity endpoints of alpelisib
por: Shields, Misty, et al.
Publicado: (2020)

Occult Breast Carcinoma Presenting as Scalp Metastasis
por: Costa, Ricardo L.B., et al.
Publicado: (2017)

Modelling Proteasome and Proteasome Regulator Activities
por: Liepe, Juliane, et al.
Publicado: (2014)

Deubiquitination Reactions on the Proteasome for Proteasome Versatility
por: Shin, Ji Yeong, et al.
Publicado: (2020)

FOXP3 and Tip60 Structural Interactions Relevant to IPEX Development Lead to Potential Therapeutics to Increase FOXP3 Dependent Suppressor T Cell Functions
por: Grover, Payal, et al.
Publicado: (2021)

Proteasome in action: substrate degradation by the 26S proteasome
por: Sahu, Indrajit, et al.
Publicado: (2021)

Identification of Nitric Oxide as an Endogenous Inhibitor of 26S Proteasomes in Vascular Endothelial Cells
por: Liu, Hongtao, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_v0phukpb90f5arj8j0jqfr3mvd